These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20145515)

  • 1. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
    Ding Y; Bushell A; Wood KJ
    Transplantation; 2010 Feb; 89(3):270-3. PubMed ID: 20145515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.
    Ding Y; Xu D; Feng G; Bushell A; Muschel RJ; Wood KJ
    Diabetes; 2009 Aug; 58(8):1797-806. PubMed ID: 19509016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
    Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
    Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation.
    Reading JL; Sabbah S; Busch S; Tree TI
    Curr Opin Organ Transplant; 2013 Feb; 18(1):59-64. PubMed ID: 23222174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of mesenchymal stromal cells for improving islet transplantation outcomes.
    Rackham CL; Jones PM
    Curr Opin Pharmacol; 2018 Dec; 43():34-39. PubMed ID: 30103073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-transplantation of Xenogeneic Bone Marrow-derived Mesenchymal Stem Cells Alleviates Rejection of Pancreatic Islets in Non-obese Diabetic Mice.
    Corradi-Perini C; Santos TM; Camara NOS; Riella MC; Aita CAM
    Transplant Proc; 2017 May; 49(4):902-905. PubMed ID: 28457422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
    Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
    Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.
    Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ
    Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet cell transplantation for insulin-dependent diabetes.
    Lacy PE
    Hosp Pract (1995); 1995 Jun; 30(6):41-5. PubMed ID: 7782398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
    Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H
    J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of mesenchymal stromal cells in pancreatic islet transplantation.
    Hematti P; Kim J; Stein AP; Kaufman D
    Transplant Rev (Orlando); 2013 Jan; 27(1):21-9. PubMed ID: 23290684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus.
    Qu Z; Lou Q; Cooper DKC; Pu Z; Lu Y; Chen J; Ni Y; Zhan Y; Chen J; Li Z; Zhan N; Zeng Y; Tu Z; Cao H; Dai Y; Cai Z; Mou L
    Xenotransplantation; 2021 May; 28(3):e12678. PubMed ID: 33569837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
    Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
    Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet transplantation in the twenty-first century.
    Thomas FT; Hutchings A; Contreras J; Wu J; Jiang XL; Eckhoff D; Thomas JM
    Immunol Res; 2002; 26(1-3):289-96. PubMed ID: 12403366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreas transplantation: is islet transplantation the future?
    Fernandez-Cruz L; Casanovas D; Lloveras G
    Transplant Proc; 1992 Dec; 24(6):2379-82. PubMed ID: 1465802
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
    Ben Nasr M; Vergani A; Avruch J; Liu L; Kefaloyianni E; D'Addio F; Tezza S; Corradi D; Bassi R; Valderrama-Vasquez A; Usuelli V; Kim J; Azzi J; El Essawy B; Markmann J; Abdi R; Fiorina P
    Acta Diabetol; 2015 Oct; 52(5):917-27. PubMed ID: 25808641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction for islet transplantation.
    Exner BG; Fowler K; Ildstad ST
    Ann Transplant; 1997; 2(3):77-80. PubMed ID: 9869869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.